Revolutionary Migraine Drug Given Seal of Approval!
The drug is Aimovig, and it’s made by Amgen in partnership with Novartis. However, it will cost $6,900 a year. A wave of new treatments, of which Aimovig is the first to get the seal of approval, are going after the huge market for migraine drugs.